Leigh MacMillan

October 1, 2015

Hochmair set for next Discovery Lecture

The co-creator of the world’s first microelectronic multi-channel cochlear implant — a device that provides sound signals to the brain in deaf individuals — will deliver the next Flexner Discovery Lecture.

By Leigh MacMillan
September 18, 2015

Nerve cell remodelers

Vanderbilt investigators have defined a gene expression program that controls the timing of synaptic remodeling – a process that is critical to brain development, learning and memory.

By Leigh MacMillan
September 17, 2015

Discovery Lecture explores health care cost controls

“There’s no magic bullet” to control rising health care costs in the United States, health law expert Timothy Jost, J.D., said during last week’s Flexner Discovery Lecture.

By Leigh MacMillan
September 8, 2015

Immune cells and obesity

Understanding how macrophage immune cells accumulate in fat tissue and contribute to the pathology of obesity could lead to the development of novel therapeutics for metabolic disorders.

By Leigh MacMillan
September 4, 2015

Vitamin C protects blood vessel lining

Dietary vitamin C may maintain healthy blood vessels in patients with inflammatory diseases.

By Leigh MacMillan
September 3, 2015

Jost set for Sept. 10 Discovery Lecture

The Flexner Discovery Lecture Series kicks off this fall with a discussion of health care cost control. Timothy Jost, J.D., emeritus professor at the Washington and Lee University School of Law, will speak on Thursday, Sept. 10.

By Leigh MacMillan
August 26, 2015

Framework for studying cell responses

Vanderbilt investigators have developed a framework for studying cellular responses that could be used to identify the agents driving a range of biological processes in health and disease.
By Leigh MacMillan
August 21, 2015

Brain circuitry in psychosis

Functional magnetic resonance imaging has revealed faulty circuits between the thalamus – a central hub of brain activity – and other brain regions.
By Leigh MacMillan
August 20, 2015

New therapeutic target for diabetes

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes.
By Leigh MacMillan
August 13, 2015

VUMC study shifts thinking on how bone fractures heal

New findings show that fibrin, a protein that was thought to play a key role in fracture healing, is not required, shifting understanding of how fractures heal.
By Leigh MacMillan
August 12, 2015

Origins of neuroblastoma

Vanderbilt researchers are exploring how neuroblastoma tumors begin and progress, knowledge that could provide new treatments for this pediatric cancer.
By Leigh MacMillan
August 11, 2015

Drug combos enhance ovarian cancer cell death

Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.
By Leigh MacMillan
1 … 50 51 52 53 54 … 79